These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18779078)

  • 1. Computational prediction models for early detection of risk of cardiovascular events using mass spectrometry data.
    Pham TD; Wang H; Zhou X; Beck D; Brandl M; Hoehn G; Azok J; Brennan ML; Hazen SL; Li K; Wong ST
    IEEE Trans Inf Technol Biomed; 2008 Sep; 12(5):636-43. PubMed ID: 18779078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of biomarkers for risk stratification of cardiovascular events using genetic algorithm with recursive local floating search.
    Zhou X; Wang H; Wang J; Wang Y; Hoehn G; Azok J; Brennan ML; Hazen SL; Li K; Chang SF; Wong ST
    Proteomics; 2009 Apr; 9(8):2286-94. PubMed ID: 19337989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A machine learning perspective on the development of clinical decision support systems utilizing mass spectra of blood samples.
    Shin H; Markey MK
    J Biomed Inform; 2006 Apr; 39(2):227-48. PubMed ID: 15963765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of cardiovascular risk--PROCAM and new algorithms].
    Assmann G
    Biomed Tech (Berl); 2005; 50(7-8):227-32. PubMed ID: 16117436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid hydrolysis followed by matrix-assisted laser desorption/ionization mass spectrometry for the rapid diagnosis of serum protein biomarkers in patients with major depression.
    Lo LH; Huang TL; Shiea J
    Rapid Commun Mass Spectrom; 2009 Mar; 23(5):589-98. PubMed ID: 19165777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The linear neuron as marker selector and clinical predictor in cancer gene analysis.
    Blazadonakis ME; Zervakis M
    Comput Methods Programs Biomed; 2008 Jul; 91(1):22-35. PubMed ID: 18423925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What resides in T-wave residuum?
    Moss AJ
    J Cardiovasc Electrophysiol; 2005 Sep; 16(9):952-3. PubMed ID: 16174014
    [No Abstract]   [Full Text] [Related]  

  • 8. Protein biomarker discovery and validation: the long and uncertain path to clinical utility.
    Rifai N; Gillette MA; Carr SA
    Nat Biotechnol; 2006 Aug; 24(8):971-83. PubMed ID: 16900146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection.
    Hong YJ; Wang XD; Shen D; Zeng S
    Acta Pharmacol Sin; 2008 Oct; 29(10):1240-6. PubMed ID: 18817630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of cardiovascular oscillations for enhanced diagnosis and risk stratification in cardiac diseases and disorders.
    Akselrod S; Cerutti S; Honzikova N; Malik M; Stein P; Voss A; Hoyer D
    Biomed Tech (Berl); 2006 Oct; 51(4):276-8. PubMed ID: 17061957
    [No Abstract]   [Full Text] [Related]  

  • 11. An extended Markov blanket approach to proteomic biomarker detection from high-resolution mass spectrometry data.
    Oh JH; Gurnani P; Schorge J; Rosenblatt KP; Gao JX
    IEEE Trans Inf Technol Biomed; 2009 Mar; 13(2):195-206. PubMed ID: 19126475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer informatics by prototype networks in mass spectrometry.
    Schleif FM; Villmann T; Kostrzewa M; Hammer B; Gammerman A
    Artif Intell Med; 2009; 45(2-3):215-28. PubMed ID: 18778925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prediction of cardiovascular disease based on trace element contents in hair and a classifier of boosting decision stumps.
    Tan C; Chen H; Xia C
    Biol Trace Elem Res; 2009; 129(1-3):9-19. PubMed ID: 19066736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A framework for fuzzy expert system creation--application to cardiovascular diseases.
    Tsipouras MG; Voglis C; Fotiadis DI
    IEEE Trans Biomed Eng; 2007 Nov; 54(11):2089-105. PubMed ID: 18018705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous colorimetric evaluation of serum concentrations of bilirubin in healthy term neonates: a new methodological approach.
    Rubegni P; Cevenini G; Sbano P; Perrone S; Buonocore G; Lazzeri L; Vanni MG; Fimiani M
    Skin Res Technol; 2005 Feb; 11(1):70-5. PubMed ID: 15691262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of peptide mass fingerprint data by novel no-regret boosting method.
    Gambin A; Szczurek E; Dutkowski J; Bakun M; Dadlez M
    Comput Biol Med; 2009 May; 39(5):460-73. PubMed ID: 19386298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A feasibility study of diagnosing cardiovascular diseases based on blood/urine element analysis and consensus models.
    Chen H; Tan C; Lin Z; Wu T; Diao Y
    Comput Biol Med; 2013 Aug; 43(7):865-9. PubMed ID: 23746728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry.
    Valkenborg D; Van Sanden S; Lin D; Kasim A; Zhu Q; Haldermans P; Jansen I; Shkedy Z; Burzykowski T
    Stat Appl Genet Mol Biol; 2008; 7(2):Article12. PubMed ID: 18384267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.